| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acellular pertussis vaccine effectiveness and waning immunity in Alberta, Canada: 2010–2015, a Canadian Immunization Research Network (CIRN) study
|
Bell, Christopher A.
|
|
2019
|
37 |
30 |
p. 4140-4146
|
article
|
| 2 |
Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines
|
Teixeira, Aline F.
|
|
2019
|
37 |
30 |
p. 3961-3973
|
article
|
| 3 |
Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine
|
Quintel, Benjamin K.
|
|
2019
|
37 |
30 |
p. 4214-4221
|
article
|
| 4 |
A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits
|
Mulama, David H.
|
|
2019
|
37 |
30 |
p. 4184-4194
|
article
|
| 5 |
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
|
Woods, Christopher W.
|
|
2019
|
37 |
30 |
p. 4222-4230
|
article
|
| 6 |
Antibody-mediated protection against MERS-CoV in the murine model
|
New, R.R.C.
|
|
2019
|
37 |
30 |
p. 4094-4102
|
article
|
| 7 |
A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands
|
Gessner, Bradford D.
|
|
2019
|
37 |
30 |
p. 4147-4154
|
article
|
| 8 |
A rationally designed flagellin-L2 fusion protein induced serum and mucosal neutralizing antibodies against multiple HPV types
|
Zhang, Ting
|
|
2019
|
37 |
30 |
p. 4022-4030
|
article
|
| 9 |
Are providers’ recommendation and knowledge associated with uptake of optional vaccinations among children? A multilevel analysis in three provinces of China
|
Chang, Jie
|
|
2019
|
37 |
30 |
p. 4133-4139
|
article
|
| 10 |
Characterization of protective humoral and cellular immune responses against RHDV2 induced by a new vaccine based on recombinant baculovirus
|
Müller, Claudia
|
|
2019
|
37 |
30 |
p. 4195-4203
|
article
|
| 11 |
Chitosan alters inactivated respiratory syncytial virus vaccine elicited immune responses without affecting lung histopathology in mice
|
Muralidharan, Abenaya
|
|
2019
|
37 |
30 |
p. 4031-4039
|
article
|
| 12 |
Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines
|
Manara, Cristina
|
|
2019
|
37 |
30 |
p. 4204-4213
|
article
|
| 13 |
Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017–2018 influenza season
|
DeMarcus, Laurie
|
|
2019
|
37 |
30 |
p. 4015-4021
|
article
|
| 14 |
Corrigendum to “An improved conjugate vaccine technology; induction of antibody responses to the tumor vasculature” [Vaccine 36(21) 3054–3060]
|
Huijbers, Elisabeth J.M.
|
|
2019
|
37 |
30 |
p. 4231-4232
|
article
|
| 15 |
Disparities in hepatitis A virus (HAV) vaccination coverage among adult travelers to intermediate or high-risk countries: The role of birthplace and race/ethnicity
|
Narayanan, Navaneeth
|
|
2019
|
37 |
30 |
p. 4111-4117
|
article
|
| 16 |
Duration of immunity to measles, rubella and mumps during the first year of life
|
Cilleruelo, María José
|
|
2019
|
37 |
30 |
p. 4164-4171
|
article
|
| 17 |
Editorial Board/Aims and Scope
|
|
|
2019
|
37 |
30 |
p. IFC
|
article
|
| 18 |
Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013–18
|
Shinjoh, Masayoshi
|
|
2019
|
37 |
30 |
p. 4047-4054
|
article
|
| 19 |
Fasciotomy following immunization: A cautionary case
|
Atchley, Taylor J.
|
|
2019
|
37 |
30 |
p. 3938-3939
|
article
|
| 20 |
Herd immunity and primary immune deficiencies
|
Farrugia, Albert
|
|
2019
|
37 |
30 |
p. 3942-3943
|
article
|
| 21 |
Heroin vaccine: Using titer, affinity, and antinociception as metrics when examining sex and strain differences
|
Hwang, Candy S.
|
|
2019
|
37 |
30 |
p. 4155-4163
|
article
|
| 22 |
Home-based records’ quality and validity of caregivers’ recall of children’s vaccination in Lebanon
|
Mansour, Ziad
|
|
2019
|
37 |
30 |
p. 4177-4183
|
article
|
| 23 |
Immune response and protective efficacy of the S particle presented rotavirus VP8* vaccine in mice
|
Xia, Ming
|
|
2019
|
37 |
30 |
p. 4103-4110
|
article
|
| 24 |
Immunization of preterms with hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: The position of the Italian Pediatric Society
|
Russo, Rocco
|
|
2019
|
37 |
30 |
p. 3944
|
article
|
| 25 |
Impact on antitumor response using a new adjuvant preparation as a component of a human papillomavirus type 16 therapeutic vaccine candidate
|
Granadillo, Milaid
|
|
2019
|
37 |
30 |
p. 3957-3960
|
article
|
| 26 |
Lack of impact of rotavirus vaccination on childhood seizure hospital attendances in Portugal – An interrupted time series analysis
|
Marlow, Robin
|
|
2019
|
37 |
30 |
p. 3940-3941
|
article
|
| 27 |
Letter to Editor
|
Watson, Philip S.
|
|
2019
|
37 |
30 |
p. 3949
|
article
|
| 28 |
Measuring the impact of a mandatory province-wide vaccinate-or-mask policy on healthcare worker absenteeism in British Columbia, Canada
|
Murti, Michelle
|
|
2019
|
37 |
30 |
p. 4008-4014
|
article
|
| 29 |
Measuring the impact of influenza vaccination on healthcare worker absenteeism in the context of a province-wide mandatory vaccinate-or-mask policy
|
Murti, Michelle
|
|
2019
|
37 |
30 |
p. 4001-4007
|
article
|
| 30 |
MMRV vaccine safety
|
Cashman, Patrick
|
|
2019
|
37 |
30 |
p. 3946
|
article
|
| 31 |
New pentavalent rotavirus vaccine shows little efficacy against diarrhea
|
Kumar, Lalit
|
|
2019
|
37 |
30 |
p. 3945
|
article
|
| 32 |
Phosphorothioated antisense oligodeoxynucleotide suppressing interleukin-10 is a safe and potent vaccine adjuvant
|
Zhang, Jin
|
|
2019
|
37 |
30 |
p. 4081-4088
|
article
|
| 33 |
Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine
|
von Mollendorf, Claire
|
|
2019
|
37 |
30 |
p. 4068-4075
|
article
|
| 34 |
Protective effect of PCV vaccine against experimental pneumococcal challenge in adults is primarily mediated by controlling colonisation density
|
German, E.L.
|
|
2019
|
37 |
30 |
p. 3953-3956
|
article
|
| 35 |
Regional variations in human papillomavirus prevalence across time in NHANES (2003–2014)
|
Hirth, Jacqueline M.
|
|
2019
|
37 |
30 |
p. 4040-4046
|
article
|
| 36 |
Rockland county’s proposed ban against unvaccinated minors: Balancing disease control, trust, and liberty
|
Bernstein, Justin
|
|
2019
|
37 |
30 |
p. 3933-3935
|
article
|
| 37 |
Safety of guidelines recommending live attenuated influenza vaccine for routine use in children and adolescents with asthma
|
Nordin, James D.
|
|
2019
|
37 |
30 |
p. 4055-4060
|
article
|
| 38 |
Some comments on the scandal of rabies vaccine in China
|
Guo, Zaidi
|
|
2019
|
37 |
30 |
p. 3936-3937
|
article
|
| 39 |
Student health administrator perspectives on college vaccine policy development and implementation
|
Fawole, Oluwatunmise A.
|
|
2019
|
37 |
30 |
p. 4118-4123
|
article
|
| 40 |
Surveillance methods to detect the impact of a significant cold chain breach
|
Najjar, Zeina
|
|
2019
|
37 |
30 |
p. 3950-3952
|
article
|
| 41 |
The advances in brucellosis vaccines
|
Hou, Huanhuan
|
|
2019
|
37 |
30 |
p. 3981-3988
|
article
|
| 42 |
The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines
|
Yang, Han
|
|
2019
|
37 |
30 |
p. 4061-4067
|
article
|
| 43 |
The relative effects of determinants on Chinese adults’ decision for influenza vaccination choice: What is the effect of priming?
|
Liao, Qiuyan
|
|
2019
|
37 |
30 |
p. 4124-4132
|
article
|
| 44 |
Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene
|
Beissbarth, Jemima
|
|
2019
|
37 |
30 |
p. 4089-4093
|
article
|
| 45 |
Using economic and social data to improve veterinary vaccine development: Learning lessons from human vaccinology
|
Thomas, Lian F.
|
|
2019
|
37 |
30 |
p. 3974-3980
|
article
|
| 46 |
Vaccination challenges and strategies against long-lived Toxoplasma gondii
|
Loh, Fei-Kean
|
|
2019
|
37 |
30 |
p. 3989-4000
|
article
|
| 47 |
Vaccine hesitancy terminology: A response to Bedford et al.
|
MacDonald, Noni
|
|
2019
|
37 |
30 |
p. 3947-3948
|
article
|
| 48 |
Vaccine immune response, autoimmunity and morbidity after neonatal blood exchange transfusion
|
Nosan, Gregor
|
|
2019
|
37 |
30 |
p. 4076-4080
|
article
|
| 49 |
Validation of febrile seizures identified in the Sentinel Post-Licensure Rapid Immunization Safety Monitoring Program
|
Kawai, Alison Tse
|
|
2019
|
37 |
30 |
p. 4172-4176
|
article
|
Journal description